1,041 results on '"Ridge, John A"'
Search Results
2. Surgical Management of Locally Advanced Thyroid Cancer with Tracheal Invasion
3. Transition to Value-based Healthcare: Development, Implementation, and Results of an Optimal Surgical Care Framework at a National Cancer Institute–designated Comprehensive Cancer Center
4. The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/− systemic therapy in locally advanced head and neck cancer
5. Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria
6. Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary
7. Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
8. Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: Implications for risk‐based therapeutic intensity trials
9. Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data
10. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
11. Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria
12. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.
13. Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer
14. Determinants of delay and association with outcome in head and neck cancer: A systematic review
15. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.
16. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting
17. The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying—the head and neck cancer model
18. Timing of postoperative radiation therapy for major salivary gland cancers.
19. Survivin expression and impact on head and neck cancer outcomes
20. DeepVarveNet: Automatic detection of glacial varves with deep neural networks
21. A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311
22. An updated radiocarbon-based ice margin chronology for the last deglaciation of the North American Ice Sheet Complex
23. Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129
24. Anaplastic Thyroid Carcinoma, Version 2.2015.
25. Head and Neck Cancers, Version 1.2015.
26. Thyroid carcinoma, version 2.2014.
27. Incidence and outcomes of radiation-induced late cranial neuropathy in 10-year survivors of head and neck cancer
28. PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma
29. Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303
30. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.
31. A critical re‐analysis of constraints on the timing and rate of Laurentide Ice Sheet recession in the northeastern United States
32. Comments on the objections of certain Cherokee delegates to the proposition of the government to separate the hostile parties of the Cherokee Nation
33. Comments on the Objections of Certain Cherokee Delegates to the Propositions of the Government to Separate the Hostile Parties of the Cherokee Nation
34. Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer
35. Value and Quality of Care in Head and Neck Oncology
36. A critical re-analysis of constraints on the timing and rate of Laurentide Ice Sheet recession in the northeastern United States.
37. Early oral tongue cancer initially managed with surgery alone: Treatment of recurrence
38. The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer
39. Supplementary Figure S1 from EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
40. Supplemental Tables and Figure Legends from EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
41. Supplementary Table S1 from EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
42. Data from EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer
43. Supplementary Figure Legend from Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers
44. Data from Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303
45. Supplementary Figures 1 - 2 from Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers
46. Data Supplement from Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303
47. Supplementary Tables 1 - 3, Figures 1 - 4 from Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303
48. Supplementary Data from Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
49. Supplementary Table 1 from Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers
50. Immunological Tolerance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.